Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Historical Holders from Q4 2021 to Q3 2025

Symbol
PYXS on Nasdaq
CUSIP
747324101
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
62.9M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
27.5M
Holdings value
$30.2M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
74
Number of buys
35
Number of sells
-52
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sullivan Lara 11.21% +9.1% $7.24M $882K 7.54M +13.9% Lara Sullivan, M.D. Mar 31, 2025
GordonMD Global Investments LP 6.2% $5.33M 3.83M GordonMD Global Investments LP Jul 14, 2025
INTEGRATED CORE STRATEGIES (US) LLC 4% -26% $2.39M -$645K 2.49M -21.3% Millennium Management LLC Mar 31, 2025
BlackRock, Inc. 1.5% -68.3% $1.07M -$2.78M 927K -72.3% BlackRock, Inc. Jun 30, 2025
MILLENNIUM MANAGEMENT LLC 1.3% -73.3% $1.5M -$4.99M 818K -76.9% Millennium Management LLC Sep 30, 2025
Ridgeback Capital Investments L.P. 0.6% $345K 359K Ridgeback Capital Investments L.P. Dec 31, 2024

Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 61.6K $137K -$15.1K $2.32 2
2025 Q2 27.5M $30.2M -$2.88M $1.10 74
2025 Q1 30.2M $29.6M -$2.65M $0.98 87
2024 Q4 31.5M $49.2M -$20.8M $1.56 96
2024 Q3 27.9M $103M -$988K $3.67 91
2024 Q2 28.1M $93.1M +$16.2M $3.31 79
2024 Q1 22.9M $97.7M +$61.7M $4.26 69
2023 Q4 8.79M $15.8M +$879K $1.80 49
2023 Q3 7.76M $15.4M -$3.49M $1.99 49
2023 Q2 9.61M $24.6M -$3.31M $2.56 46
2023 Q1 10.3M $41.5M -$20.6M $4.01 45
2022 Q4 19.8M $26.5M -$1.33M $1.34 31
2022 Q3 19.4M $38.3M -$1.47M $1.97 35
2022 Q2 20M $47.7M -$655K $2.38 37
2022 Q1 18.9M $76.1M -$5.56M $4.04 43
2021 Q4 18.3M $200M +$200M $10.97 51